Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation
In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research
Scope Of Panel’s Inquiry Outlined In Letter To Members
Institutions Required To Review For Bias under PHS Proposal
NIH Begins Process Of Extramural Program “Reinvention”
RFAs available: Chemoprevention Clinical Trials
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









